Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Pietsch

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
ACS Chemical Biology|March 12, 2013
First structure of protein kinase CK2 catalytic subunit with an effective CK2β-competitive ligandJennifer Raaf, Barbara Guerra, Ines Neundorf, et al.
International Journal of Molecular Sciences|May 14, 2022
Application of a Fluorescence Anisotropy-Based Assay to Quantify Transglutaminase 2 Activity in Cell LysatesSandra Hauser, Paul Sommerfeld, Johanna Wodtke, et al.
Bioorganic & Medicinal Chemistry|November 15, 2011
New cholesterol esterase inhibitors based on rhodanine and thiazolidinedione scaffoldsSabrina Heng, William Tieu, Stephanie Hautmann, et al.
European Journal of Medicinal Chemistry|July 23, 2020
Distinct 3-disulfide-bonded isomers of tridegin differentially inhibit coagulation factor XIIIa: The influence of structural stability on bioactivityCharlotte A Bäuml, Ajay Abisheck Paul George, Thomas Schmitz, et al.
Chemmedchem|March 14, 2020
Synthesis and SAR of Tetracyclic Inhibitors of Protein Kinase CK2 Derived from Furocarbazole W16Lukas Kröger, Constantin G Daniliuc, Deeba Ensan, et al.
Angewandte Chemie (International Ed. in English)|June 7, 2014
Macrocyclic protease inhibitors with reduced peptide characterKrystle C H Chua, Markus Pietsch, Xiaozhou Zhang, et al.
Deutsche Medizinische Wochenschrift (1946)|February 25, 2017
[Chemotherapy in the Elderly with Non-Small Cell Lung Cancer: A Non-Interventional, Prospective, Multicentric Observational Study]David Felix Heigener, Gert Hoeffken, Dieter Wuerflein, et al.
Journal of Medicinal Chemistry|March 11, 2021
Development of an <sup>18</sup>F-Labeled Irreversible Inhibitor of Transglutaminase 2 as Radiometric Tool for Quantitative Expression Profiling in Cells and TissuesRobert Wodtke, Johanna Wodtke, Sandra Hauser, et al.
Chemmedchem|July 14, 2018
ω-Phthalimidoalkyl Aryl Ureas as Potent and Selective Inhibitors of Cholesterol EsteraseFlorian M Dato, Miriam Sheikh, Rocky Z Uhl, et al.
Bioorganic Chemistry|February 15, 2020
Unexpected CK2β-antagonistic functionality of bisubstrate inhibitors targeting protein kinase CK2Markus Pietsch, Kaido Viht, Alexander Schnitzler, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
ACS Chemical Biology|March 12, 2013
First structure of protein kinase CK2 catalytic subunit with an effective CK2β-competitive ligandJennifer Raaf, Barbara Guerra, Ines Neundorf, et al.
International Journal of Molecular Sciences|May 14, 2022
Application of a Fluorescence Anisotropy-Based Assay to Quantify Transglutaminase 2 Activity in Cell LysatesSandra Hauser, Paul Sommerfeld, Johanna Wodtke, et al.
Bioorganic & Medicinal Chemistry|November 15, 2011
New cholesterol esterase inhibitors based on rhodanine and thiazolidinedione scaffoldsSabrina Heng, William Tieu, Stephanie Hautmann, et al.
European Journal of Medicinal Chemistry|July 23, 2020
Distinct 3-disulfide-bonded isomers of tridegin differentially inhibit coagulation factor XIIIa: The influence of structural stability on bioactivityCharlotte A Bäuml, Ajay Abisheck Paul George, Thomas Schmitz, et al.
Chemmedchem|March 14, 2020
Synthesis and SAR of Tetracyclic Inhibitors of Protein Kinase CK2 Derived from Furocarbazole W16Lukas Kröger, Constantin G Daniliuc, Deeba Ensan, et al.
Angewandte Chemie (International Ed. in English)|June 7, 2014
Macrocyclic protease inhibitors with reduced peptide characterKrystle C H Chua, Markus Pietsch, Xiaozhou Zhang, et al.
Deutsche Medizinische Wochenschrift (1946)|February 25, 2017
[Chemotherapy in the Elderly with Non-Small Cell Lung Cancer: A Non-Interventional, Prospective, Multicentric Observational Study]David Felix Heigener, Gert Hoeffken, Dieter Wuerflein, et al.
Journal of Medicinal Chemistry|March 11, 2021
Development of an <sup>18</sup>F-Labeled Irreversible Inhibitor of Transglutaminase 2 as Radiometric Tool for Quantitative Expression Profiling in Cells and TissuesRobert Wodtke, Johanna Wodtke, Sandra Hauser, et al.
Chemmedchem|July 14, 2018
ω-Phthalimidoalkyl Aryl Ureas as Potent and Selective Inhibitors of Cholesterol EsteraseFlorian M Dato, Miriam Sheikh, Rocky Z Uhl, et al.
Bioorganic Chemistry|February 15, 2020
Unexpected CK2β-antagonistic functionality of bisubstrate inhibitors targeting protein kinase CK2Markus Pietsch, Kaido Viht, Alexander Schnitzler, et al.
Pageof 6